MENU
+Compare
YPHDF
Stock ticker: OTC
AS OF
Aug 6 closing price
Price
$475.18
Change
-$2.39 (-0.50%)
Capitalization
5.31B

YPHDF Ypsomed Holding AG Forecast, Technical & Fundamental Analysis

Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication... Show more

YPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for YPHDF with price predictions
Oct 17, 2025

YPHDF's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for YPHDF turned positive on September 22, 2025. Looking at past instances where YPHDF's MACD turned positive, the stock continued to rise in of 5 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.599) is normal, around the industry mean (10.742). P/E Ratio (59.057) is within average values for comparable stocks, (53.915). YPHDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.793). Dividend Yield (0.006) settles around the average of (0.016) among similar stocks. P/S Ratio (6.901) is also within normal values, averaging (13.572).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. YPHDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YPHDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
YPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Brunnmattstrasse 6
Phone
+41 344244111
Employees
2059
Web
https://www.ypsomed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRWSX28.540.13
+0.46%
MFS Blended Research Growth Eq R2
HFLGX11.850.04
+0.34%
Hennessy Cornerstone Large Growth Inv
NEJYX22.180.04
+0.18%
Natixis Vaughan Nelson Small Cap Y
CICAX66.450.10
+0.15%
American Funds Invmt Co of Amer 529A
TGVRX32.16-0.28
-0.86%
Thornburg International Equity R3

Groups containing YPHDF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YPHDF
1D Price
Change %
YPHDF100%
N/A
Pharmaceuticals: Other
industry (103 stocks)
10%
Poorly correlated
+0.16%
Pharmaceuticals
industry (383 stocks)
7%
Poorly correlated
-0.25%